Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
Top
..
c19early.org COVID-19 treatment researchSelect treatment..Select..
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

Excess deaths during the COVID-19 pandemic

0 500 1000 1500 2000 2500 3000 3500 4000 4500 Age-adjusted cumulative excess deaths per million Cumulative excess mortalityduring the COVID-19 pandemic c19early.org August 2025 2020 2021 2022 Data from Our World in Data - https://docs.owid.io/projects/etl/api/covid/
Analysis of excess mortality during the COVID-19 pandemic. No effective intervention for COVID-19 was widely adopted during the pandemic—the increase in excess mortality slowed only after Omicron. However 6,102 COVID-19 treatment studies—representing over 17 million hours of research by over 39,000 scientists—show that effective and safe treatments were known early in the pandemic1.
Country-level COVID-19 excess mortality data is from Our World in Data2 as of March 17, 2025. Mean age-adjusted cumulative excess mortality per million population is calculated for the 86 countries with data for the entire period. Mostert et al. show similar results for excess mortality within 47 countries. COVID-19 IFR estimates for all ages 1-100 are from Sorensen et al. Population data is from the United Nations World Population Prospects 20245 which provides demographic data within 5 year age ranges 0-4, 5-9, etc. up to 95-99, and 100+. Age adjustment uses the matching 5-year group average IFR and adjusts the results for all countries to estimate what they would be if they had the same age distribution as the United States of America.
The plots below show sensitivity analyses when not using age adjustment and when using all countries with data at each month (not restricting to countries with data for the entire period).
0 500 1000 1500 2000 2500 3000 3500 Cumulative excess deaths per million Cumulative excess mortalityduring the COVID-19 pandemic c19early.org August 2025 2020 2021 2022 Data from Our World in Data - https://docs.owid.io/projects/etl/api/covid/Sensitivity analysis - results without age adjustment
0 1000 2000 3000 4000 Age-adjusted cumulative excess deaths per million Cumulative excess mortalityduring the COVID-19 pandemic c19early.org August 2025 2020 2021 2022 Data from Our World in Data - https://docs.owid.io/projects/etl/api/covid/Sensitivity analysis - all countries with data each month 99 countrieswith data 98 countrieswith data 90 countrieswith data
References
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit